| Ascension St John Hospital | |
| 22101 Moross Rd, Detroit, Michigan 48236 | |
| (313) 343-4000 | |
| Name | Ascension St John Hospital |
|---|---|
| Type | Acute Care Hospital |
| Location | 22101 Moross Rd, Detroit, Michigan |
| Ownership | Voluntary non-profit - Church |
| Emergency Services | Yes |
| Medicare ID (CCN) | 230165 |
| NPI Number | 1114003340 |
| Organization Name | ST. JOHN HOSPITAL |
| Address | 22101 Moross Rd, Detroit, MI 48236 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 313-343-6864 |
News Archive
Researchers at Imperial College London, say that the number of British men paying for sex has doubled during the last decade and the men were more likely to have had a sexually transmitted infection (STI).
International Stem Cell Corporation, www.intlstemcell.com, announced today that the United States Patent and Trademark Office has granted ISCO patent number 7,732,202, the first of several pending patents relating to its development of human parthenogenetic Stem Cells. Human parthenogenetic stem cells are a new type of pluripotent stem cell that allows immune matching to potentially solve critical immune rejection problems, and does not involve the ethical issues that surround the use of fertilized human embryos.
Researchers at Children's Hospital of Philadelphia have found elevated levels of a biomarker related to blood vessel damage in children with SARS-CoV-2 infection, even if the children had minimal or no symptoms of COVID-19.
The field is abuzz with the word "prevention," but how to pull off this vaunted goal? It's been held back by a strange Catch-22 of cost, time, and biomarker validation. That might change with a bold initiative led by Eric Reiman, Pierre Tariot, and others at the Banner Alzheimer's Institute. For the past two years, they have been laying the groundwork for what they hope will be an era of collaborative prevention research of shared risks and shared rewards.
Sanofi announced today data from four studies of its once-daily GLP-1 receptor agonist Lyxumia that is in Phase III clinical development, including data that demonstrates positive results in type 2 diabetes patients not at goal on oral therapies or with basal insulin.
› Verified 7 days ago
| NPI Number | 1205986411 |
| Organization Name | ST. JOHN HOSPITAL AND MEDICAL CENTER |
| Address | 22101 Moross Rd, Detroit, MI 48236 |
| Hospital Type | Long Term Care Hospital |
| Phone Number | 313-343-3497 |
News Archive
Researchers at Imperial College London, say that the number of British men paying for sex has doubled during the last decade and the men were more likely to have had a sexually transmitted infection (STI).
International Stem Cell Corporation, www.intlstemcell.com, announced today that the United States Patent and Trademark Office has granted ISCO patent number 7,732,202, the first of several pending patents relating to its development of human parthenogenetic Stem Cells. Human parthenogenetic stem cells are a new type of pluripotent stem cell that allows immune matching to potentially solve critical immune rejection problems, and does not involve the ethical issues that surround the use of fertilized human embryos.
Researchers at Children's Hospital of Philadelphia have found elevated levels of a biomarker related to blood vessel damage in children with SARS-CoV-2 infection, even if the children had minimal or no symptoms of COVID-19.
The field is abuzz with the word "prevention," but how to pull off this vaunted goal? It's been held back by a strange Catch-22 of cost, time, and biomarker validation. That might change with a bold initiative led by Eric Reiman, Pierre Tariot, and others at the Banner Alzheimer's Institute. For the past two years, they have been laying the groundwork for what they hope will be an era of collaborative prevention research of shared risks and shared rewards.
Sanofi announced today data from four studies of its once-daily GLP-1 receptor agonist Lyxumia that is in Phase III clinical development, including data that demonstrates positive results in type 2 diabetes patients not at goal on oral therapies or with basal insulin.
› Verified 7 days ago
| NPI Number | 1407803810 |
| Organization Name | SELECT SPECIALTY HOSPITAL GROSSE POINTE INC |
| Address | 22101 Moross Rd, Detroit, MI 48236 |
| Hospital Type | Long Term Care Hospital |
| Phone Number | 313-343-7560 |
News Archive
Researchers at Imperial College London, say that the number of British men paying for sex has doubled during the last decade and the men were more likely to have had a sexually transmitted infection (STI).
International Stem Cell Corporation, www.intlstemcell.com, announced today that the United States Patent and Trademark Office has granted ISCO patent number 7,732,202, the first of several pending patents relating to its development of human parthenogenetic Stem Cells. Human parthenogenetic stem cells are a new type of pluripotent stem cell that allows immune matching to potentially solve critical immune rejection problems, and does not involve the ethical issues that surround the use of fertilized human embryos.
Researchers at Children's Hospital of Philadelphia have found elevated levels of a biomarker related to blood vessel damage in children with SARS-CoV-2 infection, even if the children had minimal or no symptoms of COVID-19.
The field is abuzz with the word "prevention," but how to pull off this vaunted goal? It's been held back by a strange Catch-22 of cost, time, and biomarker validation. That might change with a bold initiative led by Eric Reiman, Pierre Tariot, and others at the Banner Alzheimer's Institute. For the past two years, they have been laying the groundwork for what they hope will be an era of collaborative prevention research of shared risks and shared rewards.
Sanofi announced today data from four studies of its once-daily GLP-1 receptor agonist Lyxumia that is in Phase III clinical development, including data that demonstrates positive results in type 2 diabetes patients not at goal on oral therapies or with basal insulin.
› Verified 7 days ago
| NPI Number | 1427564855 |
| Organization Name | SELECT SPECIALTY HOSPITAL - MACOMB COUNTY INC |
| Doing Business As | SELECT SPECIALTY HOSPITAL - GROSSE POINTE |
| Address | 22101 Moross Rd, Detroit, MI 48236 |
| Hospital Type | Long Term Care Hospital |
| Phone Number | 717-972-1100 |
News Archive
Researchers at Imperial College London, say that the number of British men paying for sex has doubled during the last decade and the men were more likely to have had a sexually transmitted infection (STI).
International Stem Cell Corporation, www.intlstemcell.com, announced today that the United States Patent and Trademark Office has granted ISCO patent number 7,732,202, the first of several pending patents relating to its development of human parthenogenetic Stem Cells. Human parthenogenetic stem cells are a new type of pluripotent stem cell that allows immune matching to potentially solve critical immune rejection problems, and does not involve the ethical issues that surround the use of fertilized human embryos.
Researchers at Children's Hospital of Philadelphia have found elevated levels of a biomarker related to blood vessel damage in children with SARS-CoV-2 infection, even if the children had minimal or no symptoms of COVID-19.
The field is abuzz with the word "prevention," but how to pull off this vaunted goal? It's been held back by a strange Catch-22 of cost, time, and biomarker validation. That might change with a bold initiative led by Eric Reiman, Pierre Tariot, and others at the Banner Alzheimer's Institute. For the past two years, they have been laying the groundwork for what they hope will be an era of collaborative prevention research of shared risks and shared rewards.
Sanofi announced today data from four studies of its once-daily GLP-1 receptor agonist Lyxumia that is in Phase III clinical development, including data that demonstrates positive results in type 2 diabetes patients not at goal on oral therapies or with basal insulin.
› Verified 7 days ago
| NPI Number | 1649355918 |
| Organization Name | ST. JOHN HOSPITAL |
| Address | 22101 Moross Rd, Detroit, MI 48236 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 313-343-6864 |
News Archive
Researchers at Imperial College London, say that the number of British men paying for sex has doubled during the last decade and the men were more likely to have had a sexually transmitted infection (STI).
International Stem Cell Corporation, www.intlstemcell.com, announced today that the United States Patent and Trademark Office has granted ISCO patent number 7,732,202, the first of several pending patents relating to its development of human parthenogenetic Stem Cells. Human parthenogenetic stem cells are a new type of pluripotent stem cell that allows immune matching to potentially solve critical immune rejection problems, and does not involve the ethical issues that surround the use of fertilized human embryos.
Researchers at Children's Hospital of Philadelphia have found elevated levels of a biomarker related to blood vessel damage in children with SARS-CoV-2 infection, even if the children had minimal or no symptoms of COVID-19.
The field is abuzz with the word "prevention," but how to pull off this vaunted goal? It's been held back by a strange Catch-22 of cost, time, and biomarker validation. That might change with a bold initiative led by Eric Reiman, Pierre Tariot, and others at the Banner Alzheimer's Institute. For the past two years, they have been laying the groundwork for what they hope will be an era of collaborative prevention research of shared risks and shared rewards.
Sanofi announced today data from four studies of its once-daily GLP-1 receptor agonist Lyxumia that is in Phase III clinical development, including data that demonstrates positive results in type 2 diabetes patients not at goal on oral therapies or with basal insulin.
› Verified 7 days ago
| NPI Number | 1669557922 |
| Organization Name | ST JOHN HOSPITAL AND MEDICAL CENTER |
| Address | 22101 Moross Rd, Detroit, MI 48236 |
| Hospital Type | General Acute Care Hospital - Critical Access |
| Phone Number | 313-343-4766 |
News Archive
Researchers at Imperial College London, say that the number of British men paying for sex has doubled during the last decade and the men were more likely to have had a sexually transmitted infection (STI).
International Stem Cell Corporation, www.intlstemcell.com, announced today that the United States Patent and Trademark Office has granted ISCO patent number 7,732,202, the first of several pending patents relating to its development of human parthenogenetic Stem Cells. Human parthenogenetic stem cells are a new type of pluripotent stem cell that allows immune matching to potentially solve critical immune rejection problems, and does not involve the ethical issues that surround the use of fertilized human embryos.
Researchers at Children's Hospital of Philadelphia have found elevated levels of a biomarker related to blood vessel damage in children with SARS-CoV-2 infection, even if the children had minimal or no symptoms of COVID-19.
The field is abuzz with the word "prevention," but how to pull off this vaunted goal? It's been held back by a strange Catch-22 of cost, time, and biomarker validation. That might change with a bold initiative led by Eric Reiman, Pierre Tariot, and others at the Banner Alzheimer's Institute. For the past two years, they have been laying the groundwork for what they hope will be an era of collaborative prevention research of shared risks and shared rewards.
Sanofi announced today data from four studies of its once-daily GLP-1 receptor agonist Lyxumia that is in Phase III clinical development, including data that demonstrates positive results in type 2 diabetes patients not at goal on oral therapies or with basal insulin.
› Verified 7 days ago
| NPI Number | 1679888374 |
| Organization Name | ST JOHN PROVIDENCE |
| Address | 22101 Moross Rd, Detroit, MI 48236 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 313-343-4000 |
News Archive
Researchers at Imperial College London, say that the number of British men paying for sex has doubled during the last decade and the men were more likely to have had a sexually transmitted infection (STI).
International Stem Cell Corporation, www.intlstemcell.com, announced today that the United States Patent and Trademark Office has granted ISCO patent number 7,732,202, the first of several pending patents relating to its development of human parthenogenetic Stem Cells. Human parthenogenetic stem cells are a new type of pluripotent stem cell that allows immune matching to potentially solve critical immune rejection problems, and does not involve the ethical issues that surround the use of fertilized human embryos.
Researchers at Children's Hospital of Philadelphia have found elevated levels of a biomarker related to blood vessel damage in children with SARS-CoV-2 infection, even if the children had minimal or no symptoms of COVID-19.
The field is abuzz with the word "prevention," but how to pull off this vaunted goal? It's been held back by a strange Catch-22 of cost, time, and biomarker validation. That might change with a bold initiative led by Eric Reiman, Pierre Tariot, and others at the Banner Alzheimer's Institute. For the past two years, they have been laying the groundwork for what they hope will be an era of collaborative prevention research of shared risks and shared rewards.
Sanofi announced today data from four studies of its once-daily GLP-1 receptor agonist Lyxumia that is in Phase III clinical development, including data that demonstrates positive results in type 2 diabetes patients not at goal on oral therapies or with basal insulin.
› Verified 7 days ago
| NPI Number | 1730264003 |
| Organization Name | ST. JOHN HOSPITAL |
| Address | 22101 Moross Rd, Detroit, MI 48236 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 313-343-6864 |
News Archive
Researchers at Imperial College London, say that the number of British men paying for sex has doubled during the last decade and the men were more likely to have had a sexually transmitted infection (STI).
International Stem Cell Corporation, www.intlstemcell.com, announced today that the United States Patent and Trademark Office has granted ISCO patent number 7,732,202, the first of several pending patents relating to its development of human parthenogenetic Stem Cells. Human parthenogenetic stem cells are a new type of pluripotent stem cell that allows immune matching to potentially solve critical immune rejection problems, and does not involve the ethical issues that surround the use of fertilized human embryos.
Researchers at Children's Hospital of Philadelphia have found elevated levels of a biomarker related to blood vessel damage in children with SARS-CoV-2 infection, even if the children had minimal or no symptoms of COVID-19.
The field is abuzz with the word "prevention," but how to pull off this vaunted goal? It's been held back by a strange Catch-22 of cost, time, and biomarker validation. That might change with a bold initiative led by Eric Reiman, Pierre Tariot, and others at the Banner Alzheimer's Institute. For the past two years, they have been laying the groundwork for what they hope will be an era of collaborative prevention research of shared risks and shared rewards.
Sanofi announced today data from four studies of its once-daily GLP-1 receptor agonist Lyxumia that is in Phase III clinical development, including data that demonstrates positive results in type 2 diabetes patients not at goal on oral therapies or with basal insulin.
› Verified 7 days ago
| NPI Number | 1750517678 |
| Organization Name | ST. JOHN HOSPITAL AND MEDICAL CENTER |
| Address | 22101 Moross Rd, Detroit, MI 48236 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 313-343-3878 |
News Archive
Researchers at Imperial College London, say that the number of British men paying for sex has doubled during the last decade and the men were more likely to have had a sexually transmitted infection (STI).
International Stem Cell Corporation, www.intlstemcell.com, announced today that the United States Patent and Trademark Office has granted ISCO patent number 7,732,202, the first of several pending patents relating to its development of human parthenogenetic Stem Cells. Human parthenogenetic stem cells are a new type of pluripotent stem cell that allows immune matching to potentially solve critical immune rejection problems, and does not involve the ethical issues that surround the use of fertilized human embryos.
Researchers at Children's Hospital of Philadelphia have found elevated levels of a biomarker related to blood vessel damage in children with SARS-CoV-2 infection, even if the children had minimal or no symptoms of COVID-19.
The field is abuzz with the word "prevention," but how to pull off this vaunted goal? It's been held back by a strange Catch-22 of cost, time, and biomarker validation. That might change with a bold initiative led by Eric Reiman, Pierre Tariot, and others at the Banner Alzheimer's Institute. For the past two years, they have been laying the groundwork for what they hope will be an era of collaborative prevention research of shared risks and shared rewards.
Sanofi announced today data from four studies of its once-daily GLP-1 receptor agonist Lyxumia that is in Phase III clinical development, including data that demonstrates positive results in type 2 diabetes patients not at goal on oral therapies or with basal insulin.
› Verified 7 days ago
| NPI Number | 1821173196 |
| Organization Name | ST JOHN HOSPITAL |
| Address | 22101 Moross Rd, Detroit, MI 48236 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 313-343-4766 |
News Archive
Researchers at Imperial College London, say that the number of British men paying for sex has doubled during the last decade and the men were more likely to have had a sexually transmitted infection (STI).
International Stem Cell Corporation, www.intlstemcell.com, announced today that the United States Patent and Trademark Office has granted ISCO patent number 7,732,202, the first of several pending patents relating to its development of human parthenogenetic Stem Cells. Human parthenogenetic stem cells are a new type of pluripotent stem cell that allows immune matching to potentially solve critical immune rejection problems, and does not involve the ethical issues that surround the use of fertilized human embryos.
Researchers at Children's Hospital of Philadelphia have found elevated levels of a biomarker related to blood vessel damage in children with SARS-CoV-2 infection, even if the children had minimal or no symptoms of COVID-19.
The field is abuzz with the word "prevention," but how to pull off this vaunted goal? It's been held back by a strange Catch-22 of cost, time, and biomarker validation. That might change with a bold initiative led by Eric Reiman, Pierre Tariot, and others at the Banner Alzheimer's Institute. For the past two years, they have been laying the groundwork for what they hope will be an era of collaborative prevention research of shared risks and shared rewards.
Sanofi announced today data from four studies of its once-daily GLP-1 receptor agonist Lyxumia that is in Phase III clinical development, including data that demonstrates positive results in type 2 diabetes patients not at goal on oral therapies or with basal insulin.
› Verified 7 days ago
| Able to receive lab results electronically | Yes |
| Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Researchers at Imperial College London, say that the number of British men paying for sex has doubled during the last decade and the men were more likely to have had a sexually transmitted infection (STI).
International Stem Cell Corporation, www.intlstemcell.com, announced today that the United States Patent and Trademark Office has granted ISCO patent number 7,732,202, the first of several pending patents relating to its development of human parthenogenetic Stem Cells. Human parthenogenetic stem cells are a new type of pluripotent stem cell that allows immune matching to potentially solve critical immune rejection problems, and does not involve the ethical issues that surround the use of fertilized human embryos.
Researchers at Children's Hospital of Philadelphia have found elevated levels of a biomarker related to blood vessel damage in children with SARS-CoV-2 infection, even if the children had minimal or no symptoms of COVID-19.
The field is abuzz with the word "prevention," but how to pull off this vaunted goal? It's been held back by a strange Catch-22 of cost, time, and biomarker validation. That might change with a bold initiative led by Eric Reiman, Pierre Tariot, and others at the Banner Alzheimer's Institute. For the past two years, they have been laying the groundwork for what they hope will be an era of collaborative prevention research of shared risks and shared rewards.
Sanofi announced today data from four studies of its once-daily GLP-1 receptor agonist Lyxumia that is in Phase III clinical development, including data that demonstrates positive results in type 2 diabetes patients not at goal on oral therapies or with basal insulin.
› Verified 7 days ago
Sinai-grace Hospital Acute Care Hospital Location: 6071 W Outer Drive, Detroit, Michigan 48235 Phone: (313) 966-3300 | |
Henry Ford Hospital Acute Care Hospital Location: 2799 W Grand Blvd, Detroit, Michigan 48202 Phone: (313) 916-2600 | |
Harper University Hospital Acute Care Hospital Location: 3990 John R Street, Detroit, Michigan 48201 Phone: (313) 745-6211 | |
Ascension St John Hospital Acute Care Hospital Location: 22101 Moross Rd, Detroit, Michigan 48236 Phone: (313) 343-4000 | |
Detroit Receiving Hospital Acute Care Hospital Location: 4201 St Antoine St - 2c, Detroit, Michigan 48201 Phone: (313) 745-2941 | |
Karmanos Cancer Center Acute Care Hospital Location: 4100 John R, Detroit, Michigan 48201 Phone: (800) 576-6266 |